— Know what they know.
Not Investment Advice

IDYA NASDAQ

IDEAYA Biosciences, Inc.
1W: +2.4% 1M: -6.7% 3M: -7.6% YTD: -12.7% 1Y: +50.5% 3Y: +38.3% 5Y: +51.4%
$29.10
-0.44 (-1.49%)
 
Weekly Expected Move ±5.1%
$25 $27 $28 $30 $31
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 46 · $2.6B mcap · 87M float · 1.35% daily turnover · Short 68% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
45.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -35.2%  ·  5Y Avg: 209.8%
Cost Advantage
51
Intangibles
44
Switching Cost
36
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IDYA shows a Weak competitive edge (45.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -35.2% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$59
Avg Target
$59
High
Based on 14 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 23Hold: 2Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$58.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-14 Wedbush $52 $58 +6 +85.0% $31.34
2026-04-14 RBC Capital $45 $53 +8 +61.5% $32.82
2026-04-13 Truist Financial $60 $65 +5 +98.0% $32.82
2026-02-18 Wedbush Initiated $52 +68.6% $30.84
2026-01-21 RBC Capital $41 $45 +4 +25.9% $35.75
2026-01-06 Truist Financial Gregory Renza $59 $60 +1 +71.7% $34.94
2025-11-24 Truist Financial Initiated $59 +73.6% $33.99
2025-10-21 New Street Initiated $30 -1.7% $30.51
2025-10-21 RBC Capital $38 $41 +3 +34.4% $30.51
2025-09-17 Guggenheim $32 $50 +18 +104.6% $24.44
2025-09-09 RBC Capital Gregory Renza $61 $38 -23 +53.6% $24.74
2025-09-08 Oppenheimer Matthew Biegler $53 $36 -17 +53.9% $23.39
2025-09-04 JMP Securities lvan Tuerkcan Initiated $41 +59.2% $25.76
2025-09-04 Barclays Initiated $40 +54.9% $25.83
2024-11-05 Leerink Partners Andrew Berens Initiated $27 -8.7% $29.58
2024-10-23 UBS David Dai Initiated $50 +69.5% $29.50
2024-09-25 Mizuho Securities Graig Suvannavejh $50 $55 +5 +75.3% $31.37
2024-09-23 Goldman Sachs Corinne Jenkins Initiated $48 +42.3% $33.73
2024-09-23 Stifel Nicolaus Ben Burnett $68 $66 -2 +95.7% $33.73
2024-09-23 BTIG Justin Zelin Initiated $62 +83.1% $33.87
2024-09-10 Stifel Nicolaus Ben Burnett $63 $68 +5 +83.9% $36.97
2024-08-27 Citigroup Yigal Nochomovitz Initiated $58 +45.7% $39.80
2024-08-07 Oppenheimer Matthew Biegler $20 $53 +33 +47.8% $35.86
2024-07-10 RBC Capital Gregory Renza Initiated $61 +63.4% $37.33
2024-07-08 Mizuho Securities Graig Suvannavejh Initiated $50 +24.4% $40.20
2024-06-03 Stifel Nicolaus Ben Burnett Initiated $63 +62.0% $38.89
2022-12-28 Capital One Financial Initiated $29 +66.0% $17.47
2022-09-13 Guggenheim Initiated $32 +158.1% $12.40
2022-08-17 Oppenheimer Initiated $20 +103.5% $9.83
2022-08-16 Robert W. Baird Initiated $18 +67.6% $10.74

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C-
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
3
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IDYA receives an overall rating of C-. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-02-19 C C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

52 Grade D
Profitability
20
Balance Sheet
84
Earnings Quality
73
Growth
88
Value
38
Momentum
80
Safety
100
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IDYA scores highest in Safety (100/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
19.98
Safe Zone
Piotroski F-Score
3/9
Beneish M-Score
Ohlson O-Score
-7.89
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A+
Score: 75.6/100
Trend: Stable
Earnings Quality
OCF/NI: 0.61x
Accruals: -4.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IDYA scores 19.98, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IDYA scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IDYA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IDYA receives an estimated rating of A+ (score: 75.6/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-18.43x
PEG
-0.42x
P/S
11.35x
P/B
2.75x
P/FCF
-33.61x
P/OCF
EV/EBITDA
-14.95x
EV/Revenue
10.41x
EV/EBIT
-14.53x
EV/FCF
-26.66x
Earnings Yield
-4.74%
FCF Yield
-2.98%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IDYA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
0.868
EBT / EBIT
×
EBIT Margin
-0.716
EBIT / Rev
×
Asset Turnover
0.202
Rev / Assets
×
Equity Multiplier
1.073
Assets / Equity
=
ROE
-13.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IDYA's ROE of -13.5% is driven by Asset Turnover (0.202), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1760 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$29.10
Median 1Y
$25.75
5th Pctile
$7.94
95th Pctile
$83.31
Ann. Volatility
72.2%
Analyst Target
$58.67
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Yujiro S. Hata
President and Chief Executive Officer
$700,000 $— $9,512,640
Joshua Bleharski, Ph.D.
Chief Financial Officer
$333,333 $— $4,147,322
Darrin M. Beaupre,
M.D., Ph.D. Chief Medical Officer
$526,500 $— $3,334,109
Michael A. White,
Ph.D. Chief Scientific Officer
$519,000 $— $3,324,109
Andres Ruiz Briseno
Chief Accounting Officer
$417,000 $— $1,653,155
Douglas B. Snyder
Chief Legal Officer
$440,000 $— $1,131,560

CEO Pay Ratio

30008:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,512,640
Avg Employee Cost (SGA/emp): $317
Employees: 200,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
200,000
+152571.8% YoY
Revenue / Employee
$1,094
Rev: $218,710,000
Profit / Employee
$-568
NI: $-113,698,000
SGA / Employee
$317
Avg labor cost proxy
R&D / Employee
$1,574
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -20.1% -24.6% -19.9% -21.9% -26.4% -21.1% -18.0% -21.0% -22.8% -31.7% -23.3% -26.6% -31.7% -36.7% -32.7% -36.6% -39.5% -19.1% -10.9% -13.5% -13.45%
ROA -14.6% -17.8% -14.6% -16.1% -19.4% -15.5% -15.2% -17.8% -19.3% -26.8% -21.8% -24.9% -29.6% -34.3% -31.0% -34.6% -37.4% -18.1% -10.2% -12.5% -12.54%
ROIC 30.6% 37.4% -66.3% -73.0% -88.1% -71.8% 4.2% 5.0% 5.6% 7.9% -1.1% -1.3% -1.5% -1.8% -64.3% -70.8% -75.5% -41.0% -30.6% -35.2% -35.23%
ROCE -11.6% -14.1% -14.8% -16.3% -19.6% -15.7% -16.5% -19.2% -20.8% -29.0% -18.2% -20.7% -24.7% -28.6% -25.5% -28.5% -30.8% -14.9% -11.9% -15.4% -15.36%
Gross Margin -71.1% -72.7% 85.7% 95.9% 79.4% 96.9% 86.1% 87.8% 71.8% 87.7% 73.9% 90.8% 99.5% 1.0% 82.6% 82.58%
Operating Margin -1.3% -1.3% -6.2% -1.3% -3.8% 2.2% -6.6% -3.3% -9.2% -4.2% -10.7% -20.6% 52.2% -8.7% -16.5% -16.55%
Net Margin -1.3% -1.3% -6.1% -1.2% -3.8% 5.4% -6.0% -3.0% -7.9% -3.4% -8.7% -18.6% 57.4% -7.7% -15.0% -15.02%
EBITDA Margin -1.2% -1.2% -6.0% -1.2% -3.6% 8.6% -5.9% -2.9% -7.6% -3.3% -8.4% -18.5% 57.9% -8.6% -16.4% -16.37%
FCF Margin 1.4% -1.5% -2.1% -2.0% -2.5% -1.7% -1.8% -2.1% -2.5% -5.0% -5.0% -8.7% -11.2% -39.1% -35.9% -38.3% -42.5% -49.1% -33.6% -39.0% -39.03%
OCF Margin 1.5% -1.4% -2.0% -1.9% -2.4% -1.6% -1.7% -2.0% -2.4% -4.9% -4.9% -8.5% -10.9% -38.2% -35.4% -37.7% -42.0% -47.6% -32.5% -38.1% -38.14%
ROE 3Y Avg snapshot only -21.15%
ROE 5Y Avg snapshot only -20.23%
ROA 3Y Avg snapshot only -19.93%
ROIC Economic snapshot only -13.85%
Cash ROA snapshot only -7.75%
Cash ROIC snapshot only -20.88%
CROIC snapshot only -21.37%
NOPAT Margin snapshot only -64.34%
Pretax Margin snapshot only -62.17%
R&D / Revenue snapshot only 1.51%
SGA / Revenue snapshot only 29.71%
SBC / Revenue snapshot only 10.69%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -22.97 -26.24 -18.29 -7.89 -8.10 -11.65 -14.91 -9.73 -17.83 -15.68 -20.55 -25.57 -17.80 -15.33 -8.18 -4.71 -5.60 -15.18 -26.93 -21.10 -18.429
P/S Ratio 19.40 27.08 32.57 13.47 18.30 12.30 17.17 14.00 29.28 68.93 99.27 212.56 228.85 696.01 320.67 206.75 265.67 11.36 14.00 13.12 11.350
P/B Ratio 3.48 4.86 3.02 1.43 1.77 2.03 2.50 1.90 3.78 4.63 3.74 5.31 4.41 4.40 2.12 1.37 1.76 2.30 2.99 2.89 2.754
P/FCF 13.80 -18.19 -15.58 -6.77 -7.39 -7.26 -9.65 -6.75 -11.92 -13.91 -19.74 -24.44 -20.37 -17.81 -8.93 -5.40 -6.26 -23.16 -41.68 -33.61 -33.611
P/OCF 13.27
EV/EBITDA -14.44 -19.57 -13.91 -3.59 -4.61 -7.49 -9.25 -4.68 -13.58 -12.61 -16.51 -22.22 -14.81 -12.70 -5.87 -2.61 -3.67 -11.38 -20.36 -14.95 -14.953
EV/Revenue 11.61 19.29 23.93 5.94 10.02 7.45 10.08 6.38 21.28 53.54 76.94 178.88 185.19 562.89 226.79 112.87 171.79 8.30 11.21 10.41 10.405
EV/EBIT -13.75 -18.70 -13.44 -3.47 -4.43 -7.06 -8.75 -4.43 -12.95 -12.18 -15.93 -21.52 -14.41 -12.40 -5.78 -2.57 -3.62 -11.09 -19.61 -14.53 -14.526
EV/FCF 8.26 -12.96 -11.44 -2.98 -4.05 -4.40 -5.66 -3.08 -8.66 -10.80 -15.30 -20.57 -16.49 -14.41 -6.31 -2.95 -4.05 -16.92 -33.36 -26.66 -26.657
Earnings Yield -4.4% -3.8% -5.5% -12.7% -12.3% -8.6% -6.7% -10.3% -5.6% -6.4% -4.9% -3.9% -5.6% -6.5% -12.2% -21.2% -17.8% -6.6% -3.7% -4.7% -4.74%
FCF Yield 7.2% -5.5% -6.4% -14.8% -13.5% -13.8% -10.4% -14.8% -8.4% -7.2% -5.1% -4.1% -4.9% -5.6% -11.2% -18.5% -16.0% -4.3% -2.4% -3.0% -2.98%
Price/Tangible Book snapshot only 2.889
EV/Gross Profit snapshot only 10.565
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 7.47 7.47 5.56 5.56 5.56 5.56 11.68 11.68 11.68 11.68 19.65 19.65 19.65 19.65 14.97 14.97 14.97 14.97 11.34 11.34 11.336
Quick Ratio 7.47 7.47 5.56 5.56 5.56 5.56 11.68 11.68 11.68 11.68 19.65 19.65 19.65 19.65 14.97 14.97 14.97 14.97 11.34 11.34 11.336
Debt/Equity 0.03 0.03 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.03 0.03 0.027
Net Debt/Equity -1.40 -1.40 -0.80 -0.80 -0.80 -0.80 -1.03 -1.03 -1.03 -1.03 -0.84 -0.84 -0.84 -0.84 -0.62 -0.62 -0.62 -0.62 -0.60 -0.60 -0.598
Debt/Assets 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.03 0.03 0.025
Debt/EBITDA -0.24 -0.19 -0.11 -0.10 -0.08 -0.10 -0.06 -0.05 -0.05 -0.03 -0.03 -0.02 -0.02 -0.02 -0.07 -0.06 -0.06 -0.12 -0.23 -0.18 -0.178
Net Debt/EBITDA 9.69 7.90 5.03 4.56 3.82 4.87 6.51 5.59 5.11 3.62 4.79 4.18 3.49 3.00 2.43 2.17 2.00 4.19 5.08 3.90 3.901
Interest Coverage
Equity Multiplier 1.50 1.50 1.26 1.26 1.26 1.26 1.11 1.11 1.11 1.11 1.05 1.05 1.05 1.05 1.06 1.06 1.06 1.06 1.08 1.08 1.084
Cash Ratio snapshot only 10.871
Cash to Debt snapshot only 22.906
FCF to Debt snapshot only -3.150
Defensive Interval snapshot only 575.8 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.17 0.17 0.08 0.09 0.09 0.15 0.13 0.12 0.12 0.06 0.05 0.03 0.02 0.01 0.01 0.01 0.01 0.24 0.20 0.20 0.202
Inventory Turnover
Receivables Turnover 37.87 37.88 18.75 21.51 19.56 33.47 77.52 72.23 68.71 35.74 204.24 135.41 104.46 34.26 666.67 666.67 666.67 20460.38 145806.67 150180.00 150180.000
Payables Turnover 32.72 51.03 27.82 20.55 11.53 1.98 0.99 1.14 1.08 1.10 0.73 0.75 0.77 0.77 0.35 0.35 0.37 0.37 0.21 0.21 0.206
DSO 10 10 19 17 19 11 5 5 5 10 2 3 3 11 1 1 1 0 0 0 0.0 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 11 7 13 18 32 185 370 319 338 332 500 485 474 471 1048 1034 999 995 1774 1768 1768.5 days
Cash Conversion Cycle -2 2 6 -1 -13 -174 -365 -314 -333 -322 -499 -483 -470 -460 -1048 -1034 -999 -995 -1774 -1768 -1768.5 days
Fixed Asset Turnover snapshot only 7.201
Cash Velocity snapshot only 0.352
Capital Intensity snapshot only 4.924
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3.0% 43.0% 19.7% -18.0% 40.3% 82.3% 48.0% 54.9% -52.9% -54.1% -67.3% -73.5% -83.3% -70.1% -54.9% -41.5% 53.8% 30.2% 31.2% 31.18%
Net Income 35.0% 8.6% -44.3% -74.0% -1.2% -43.6% -17.9% -24.7% -12.6% -96.0% -92.6% -88.8% -1.1% -72.6% -1.4% -1.4% -1.2% 9.8% 58.6% 54.4% 54.39%
EPS 58.4% 31.3% -9.2% -43.2% -86.4% -31.9% 5.7% 0.5% 22.6% -34.3% -42.1% -21.6% -49.6% -20.1% -81.5% -1.0% -90.2% 13.3% 59.2% 54.6% 54.57%
FCF 2.2% -1.9% -2.1% -2.3% -2.4% -59.6% -55.1% -54.5% -53.6% -37.7% -29.8% -37.0% -21.2% -31.7% -1.1% -98.7% -1.2% 31.2% 70.8% 67.2% 67.19%
EBITDA 36.2% 9.6% -45.2% -76.4% -1.2% -41.7% -15.5% -22.0% -11.8% -1.0% -96.4% -93.1% -1.1% -74.4% -1.5% -1.4% -1.2% 9.9% 55.5% 48.3% 48.30%
Op. Income 36.6% 10.2% -42.2% -73.0% -1.2% -46.4% -24.3% -34.7% -26.9% -1.2% -1.2% -1.1% -1.3% -88.9% -1.4% -1.3% -1.0% 7.1% 51.3% 49.1% 49.09%
OCF Growth snapshot only 67.47%
Asset Growth snapshot only -1.31%
Equity Growth snapshot only -3.42%
Debt Growth snapshot only 45.61%
Shares Change snapshot only 0.39%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 37.8% 6.2% -16.7% -30.4% -52.0% -37.0% -39.8% -37.8% 62.7% 62.5% 68.1% 68.07%
Revenue 5Y 88.8% 62.1% 53.1% 53.10%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 37.9% 2.3% -7.0% -2.4% 65.8% -36.4% 65.1% 65.2% 71.7% 71.73%
Gross Profit 5Y 94.3% 64.0% 73.3% 73.35%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 58.1% 58.1% 50.9% 50.9% 50.9% 50.9% 29.6% 29.6% 29.6% 29.6% 43.4% 43.4% 43.4% 43.4% 41.9% 41.9% 41.93%
Assets 5Y 46.4% 46.4% 58.3% 58.3% 58.3% 58.3% 30.0% 30.0% 30.04%
Equity 3Y 51.5% 51.5% 51.5% 51.5% 46.3% 46.3% 46.3% 46.3% 52.0% 52.0% 52.0% 52.0% 43.0% 43.0% 43.05%
Book Value 3Y 13.5% 13.4% 9.1% 18.1% 11.9% 9.8% 9.7% 11.1% 15.7% 15.3% 15.4% 17.2% 16.7% 16.9% 16.87%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.75 0.92 0.95 0.87 0.71 0.97 0.97 0.93 0.73 0.18 0.10 0.03 0.17 0.01 0.04 0.01 0.01 0.38 0.35 0.32 0.316
Earnings Stability 0.30 0.58 0.84 0.20 0.68 0.82 0.94 0.61 0.80 0.79 0.80 0.74 0.80 0.80 0.70 0.69 0.72 0.85 0.46 0.53 0.526
Margin Stability 0.00 0.00 0.08 0.31 0.12 0.00 0.30 0.45 0.00 0.00 0.26 0.59 0.38 0.74 0.67 0.673
Rev. Growth Consistency 0.50 1.00 1.00 1.00 0.00 1.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.86 0.97 0.82 0.50 0.50 0.83 0.93 0.90 0.95 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.96 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.08 0.12 0.09 0.12 0.00 -0.03 -0.03 -0.12 -0.02 -0.02 -0.03 -0.05 -0.08 -0.09 -0.08 0.14 0.11 0.11 0.112
Gross Margin Trend 0.61 0.73 0.65 0.61 0.48 0.62 0.26 -0.01 -0.97 -0.43 -0.38 -0.36 0.59 0.34 0.39 0.394
FCF Margin Trend -4.18 -2.14 -2.01 -1.92 -3.36 -3.09 -6.67 -8.77 -35.74 -32.52 -32.90 -35.62 21.52 20.14 23.10 23.099
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -1.73 1.38 1.12 1.13 1.04 1.53 1.49 1.40 1.47 1.11 1.02 1.02 0.85 0.84 0.90 0.86 0.89 0.64 0.63 0.61 0.613
FCF/OCF 0.96 1.04 1.05 1.03 1.05 1.05 1.04 1.03 1.02 1.01 1.02 1.03 1.03 1.02 1.02 1.01 1.01 1.03 1.03 1.02 1.023
FCF/Net Income snapshot only 0.628
CapEx/Revenue 5.6% 6.2% 9.5% 6.4% 11.7% 8.1% 6.8% 6.5% 4.5% 6.5% 10.1% 23.5% 31.3% 91.6% 55.1% 55.2% 50.7% 1.5% 1.1% 0.9% 0.89%
CapEx/Depreciation snapshot only 0.436
Accruals Ratio -0.40 0.07 0.02 0.02 0.01 0.08 0.07 0.07 0.09 0.03 0.00 0.00 -0.04 -0.05 -0.03 -0.05 -0.04 -0.07 -0.04 -0.05 -0.048
Sloan Accruals snapshot only -0.036
Cash Flow Adequacy snapshot only -42.856
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -13.2% -15.7% -16.0% -24.1% -16.6% -15.9% -11.1% -14.9% -19.1% -11.3% -13.3% -19.9% -19.7% -29.3% -29.9% -24.0% -16.8% -1.1% -0.9% -0.2% -0.16%
Total Shareholder Return -13.2% -15.7% -16.0% -24.1% -16.6% -15.9% -11.1% -14.9% -19.1% -11.3% -13.3% -19.9% -19.7% -29.3% -29.9% -24.0% -16.8% -1.1% -0.9% -0.2% -0.16%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.91 0.87 0.868
EBIT Margin -0.84 -1.03 -1.78 -1.71 -2.26 -1.06 -1.15 -1.44 -1.64 -4.39 -4.83 -8.31 -12.85 -45.40 -39.21 -43.87 -47.40 -0.75 -0.57 -0.72 -0.716
Asset Turnover 0.17 0.17 0.08 0.09 0.09 0.15 0.13 0.12 0.12 0.06 0.05 0.03 0.02 0.01 0.01 0.01 0.01 0.24 0.20 0.20 0.202
Equity Multiplier 1.38 1.38 1.36 1.36 1.36 1.36 1.18 1.18 1.18 1.18 1.07 1.07 1.07 1.07 1.06 1.06 1.06 1.06 1.07 1.07 1.073
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.91 $-0.97 $-1.29 $-1.42 $-1.70 $-1.28 $-1.22 $-1.41 $-1.32 $-1.72 $-1.73 $-1.72 $-1.97 $-2.07 $-3.14 $-3.48 $-3.75 $-1.79 $-1.28 $-1.58 $-1.58
Book Value/Share $6.03 $5.25 $7.83 $7.81 $7.80 $7.33 $7.26 $7.22 $6.21 $5.82 $9.52 $8.27 $7.97 $7.21 $12.13 $11.99 $11.97 $11.81 $11.55 $11.53 $10.57
Tangible Book/Share $6.03 $5.25 $7.83 $7.81 $7.80 $7.33 $7.26 $7.22 $6.21 $5.82 $9.52 $8.27 $7.97 $7.21 $12.13 $11.99 $11.97 $11.81 $11.55 $11.53 $11.53
Revenue/Share $1.08 $0.94 $0.73 $0.83 $0.75 $1.21 $1.06 $0.98 $0.80 $0.39 $0.36 $0.21 $0.15 $0.05 $0.08 $0.08 $0.08 $2.40 $2.47 $2.54 $2.54
FCF/Share $1.52 $-1.40 $-1.52 $-1.65 $-1.87 $-2.06 $-1.88 $-2.04 $-1.97 $-1.94 $-1.80 $-1.80 $-1.72 $-1.78 $-2.88 $-3.03 $-3.36 $-1.18 $-0.83 $-0.99 $-0.99
OCF/Share $1.58 $-1.34 $-1.45 $-1.60 $-1.78 $-1.96 $-1.81 $-1.97 $-1.93 $-1.91 $-1.77 $-1.75 $-1.68 $-1.74 $-2.83 $-2.99 $-3.32 $-1.14 $-0.80 $-0.97 $-0.97
Cash/Share $8.63 $7.51 $6.41 $6.39 $6.38 $6.00 $7.58 $7.54 $6.49 $6.08 $8.05 $6.99 $6.74 $6.09 $7.74 $7.65 $7.64 $7.54 $7.22 $7.21 $7.57
EBITDA/Share $-0.87 $-0.93 $-1.25 $-1.37 $-1.64 $-1.21 $-1.15 $-1.34 $-1.26 $-1.66 $-1.67 $-1.66 $-1.92 $-2.02 $-3.10 $-3.43 $-3.70 $-1.75 $-1.36 $-1.77 $-1.77
Debt/Share $0.20 $0.18 $0.13 $0.13 $0.13 $0.13 $0.07 $0.07 $0.06 $0.06 $0.04 $0.04 $0.04 $0.03 $0.22 $0.22 $0.22 $0.21 $0.32 $0.31 $0.31
Net Debt/Share $-8.43 $-7.33 $-6.27 $-6.26 $-6.25 $-5.88 $-7.51 $-7.47 $-6.42 $-6.02 $-8.00 $-6.95 $-6.70 $-6.06 $-7.52 $-7.44 $-7.43 $-7.33 $-6.90 $-6.89 $-6.89
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 19.978
Altman Z-Prime snapshot only 36.374
Piotroski F-Score 5 3 2 3 2 3 4 3 3 2 2 2 3 3 3 2 2 4 4 3 3
Beneish M-Score -3.72 201.55 200.92 200.27 202.55 -2.95 -3.49 -3.58 -4.16 -0.48 -2.21 -3.16
Ohlson O-Score snapshot only -7.894
ROIC (Greenblatt) snapshot only -25.24%
Net-Net WC snapshot only $6.54
EVA snapshot only $-186085720.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A+
Credit Score 81.85 73.71 74.12 61.30 72.80 75.48 76.78 76.20 76.41 76.48 76.71 76.44 76.56 76.30 76.29 76.25 76.42 76.04 76.15 75.61 75.608
Credit Grade snapshot only 5
Credit Trend snapshot only -0.641
Implied Spread (bps) snapshot only 125.000
Industry Credit Rank snapshot only 76
Sector Credit Rank snapshot only 70

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms